( September 16, 2014) -- The FTC is likely to start moving more aggressively against unwarranted, bad-faith assertions of patent rights. The recent AndroGel complaint sets down a marker on that. However, the exact breadth of the effort, and the precise legal theories that will be used, are both considerably less certain than the initial claims suggest....